http//sinopharm. cra.ac.th: Covid-19 have changed our lives as it has stopped our life. Many people lost their lives or went unemployed, because of which COVID was declared as a pandemic. So, it took nearly one year to research for vaccination to fight against this fatal disease. All the vaccines are needed to be certified by WHO before starting the execution. “Sinopharm” is listed as an additional vaccine against the disease, mainly for emergency use.
This vaccine is developed by Sinopharm, which belongs to the China Pharmaceutical Group, and it is quite effective even to fight against variants of COVID. The vaccine alliance has currently accounted regarding the Advance purchase agreement of 60 million doses by Sinopharm under the COVAX facility. Not only this, but the deal also says that in the 4th quarter, WHO can ask for 60 million doses under COVAX facilities.
Why is Sinopharm in the news?
WHO has listed Sinopharm as the emergency vaccine against covid-19, mainly for front line workers and for a country where cases are increasing rapidly. Even UNICEF signed an agreement regarding the supply of the vaccine to fight against COVID and its variants.
But based on safety protocols, WHO has approved Sinopharm as an emergency vaccine under COVAX. It is the first Chinese vaccine that received approval from WHO, and millions of people in China have received the jab of it. Sinopharm have submitted all the reports and scientific results based on which WHO declared that the vaccine is nearly 78% effective. Thus, it received approval and can be given in case of emergency.
Why Sinopharm took so much time to get approval?
The manufacturers have not given information or journals regarding the last stage results. Thus, it becomes difficult to rely on it, so it took more time than other vaccines. Moreover, the vaccine does not offer a high level of scrutiny as was seen with Moderna or Pfizer, so WHO was unable to take the correct decision.
How does the Chinese vaccine Sinopharm works?
Most of the vaccine needs highly equipped storage equipment, which is one reason why many countries cannot afford it. But Sinopharm has easy storage requirements, and so nations with low storage facilities can afford it. Moreover, Sinopharm works more in the traditional manner where the vaccine kills the particles so that the immune system stays strong against the virus.
In all, the working of the Sinopharm is quite different from other European manufactured vaccines, but many people have received both their jabs and are safe. So, currently, Sinopharm is also eligible to work under COVAX and will be given to countries that need vaccines.
Who would be eligible to get Sinopharm?
Based on the reports and members of Sinopharm, people between the age of 18-59 are eligible for the vaccine. Manufacturers have low confidence in how Sinopharm will react with the age group above 60, so it is not advisable to them.